Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BICO & VITK -- Ignore unavailable to you. Want to Upgrade?

To: ROSARIO who wrote (2121)	8/17/1998 8:24:00 PM
From: Tom R. Jones	Respond to of 2395

BICO's bleak quarterly report: BICO had 316 million shares outstanding as of June 30. Cash on hand fell from nearly $3 million to under $300,000. Accounts payable shows that BICO currently must pay $1.3 million. I would guess that much of that is overdue wages. In addition, BICO has suspended sales of the electrical stimulators even though they were BICO's primary revenue for the quarter. The picture is clear...either BICO finds a revenue source or the company is history. I wonder what happened to the $50 million in revenues that BICO was to get from ICTI? Will the Diasensor sell in Europe? Regards, Tom